Skip to content

Efficacy and safety of acupuncture for acute renal colic caused by urinary calculi: a randomized controlled trial.

Efficacy and safety of acupuncture for acute renal colic caused by urinary calculi: a randomized controlled trial.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002529
Enrollment
Unknown
Registered
2019-08-16
Start date
2019-08-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute renal colic caused by urinary calculi

Interventions

Sponsors

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed according to European Association of Urology guideline (2017). 2. Aged 18–75 years (either sex). 3. Patients with moderate to severe renal colic (Visual Analogue Scale, VAS>=4). 4. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Use of any analgesia in last 6 hours. 2. Allergic to diclofenac, morphine, or anisodamine; history of asthma, urticaria or allergic rhinitis induced by taking acetylsalicylic acid or other drugs containing prostaglandin synthase inhibitors. 3. Congestive heart failure, acute ischemic heart disease, or peripheral vascular disease. 4. Acute cerebrovascular disease, increased intracranial pressure. 5. Renal or liver failure. 6. Active digestive ulcer, pyloric obstruction, or intestinal obstruction. 7. Blood system diseases: such as hemophilia, coagulation disorders in patients; Thrombocytopenia (< 50x10^9/L); Using anticoagulants. 8. Glaucoma, elevated intraocular pressure. 9. People who have had serious adverse reactions to acupuncture. 10. Acupuncture site of skin infection. 11. Have a history of mental illness or substance abuse, or have severe cognitive impairment. 12. Pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Response rate (the proportion of participants whose pain reduced >= 50% compared with baseline);

Secondary

MeasureTime frame
Visual Analogue Scale;Re-visit rate and admission rate;The rate of patients requiring additional pain relief;Response rate (the proportion of participants whose pain reduced >=50% compared with baseline);Adverse events;

Countries

China

Contacts

Public ContactZhicheng Qu

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

qzhch0824@163.com+86 15811580924

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026